Dr. Duangnate Rojanaporn (MD, FICO) graduated from Mahidol University, Bangkok, Thailand, before completing an International Council of Ophthalmology (ICO) fellowship in medical and surgical retina at New York Eye and Ear Infirmary, and a fellowship in ocular oncology at Wills Eye Hospital, USA. She is the Director of the Ocular Oncology Service, and course instructor for the Retina Service at the Department of Ophthalmology, Ramathibodi Hospital. Dr. Rojanaporn is a pioneer of plaque brachytherapy, and intra-arterial chemotherapy for retinoblastoma in the South East Asia region. She coordinates the ocular oncology program for several international conferences, and has been invited to deliver presentations at numerous local, regional, and international meetings. Dr. Rojanaporn received an ICO fellowship grant in 2008, a Professor Yasuo Tano travel grant for the Asia-Pacific Academy of Ophthalmology (APAO) meeting in 2013, and an Asia-Pacific Academy of Ophthalmology Achievement Award in 2018.
This atlas covers all aspects of retina, retinal pigment epithelium, and choroidal tumors, as well as other simulating lesions of intraocular tumors and paraneoplastic syndromes. Each chapter features numerous high-quality pictures based on multimodal imaging, including color fundus photography, fundus autofluorescence, optical coherence tomography, ultrasonography, ultra-widefield imaging, and fundus angiography.
Designed to assist in the diagnosis and treatment of posterior segment intraocular tumors and simulating lesions, this book is intended for ocular oncologists, retina specialists, general ophthalmologists, residents and retina fellows.
Ocular Oncology atlas is part of the series Retina Atlas, which provides global perspectives on vitreoretinal diseases, covering imaging basics, retinal vascular disease, macular disorders, ocular inflammatory and infectious disorders, retinal degeneration, surgical retina, ocular oncology, pediatric retina and trauma. Retina Atlas consists of 9 volumes and about 100 chapters, presenting validated and comprehensive information on retinal disorders.
